Corteva (CTVA) Misses Q3 EPS by 20c; updates guidance

Corteva (NYSE: CTVA) reported Q3 EPS of ($0.49), $0.20 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $2.46 billion versus the consensus estimate of $2.71 billion.

GUIDANCE:

Corteva sees FY2024 EPS of $2.50-$2.60, versus the consensus of $2.67. Corteva sees FY2024 revenue of $17-17.2 billion, versus the consensus of $17.229 billion.

For full-year 2025, Corteva has a preliminary outlook3 of net sales in the range of $17.3 to $17.7 billion, versus the consensus of $17.932 billion. growth of 2% at the mid-point and operating EBITDA1 in the range of $3.6 to $4.0 billion, growth of 12% at the mid-point.

For earnings history and earnings-related data on Corteva (CTVA) click here.

You May Also Be Interested In

• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Lake Street Starts Vivani Medical, Inc. (VANI) at Buy
• Italy’s Meloni said to consider April election amid falling support